@article{JTD2857,
author = {Tiago N. Machuca and Marcelo Cypel},
title = {Ex vivo lung perfusion},
journal = {Journal of Thoracic Disease},
volume = {6},
number = {8},
year = {2014},
keywords = {},
abstract = {Lung transplantation (LTx) is an established treatment option for eligible patients with end-stage lung disease. Nevertheless, the imbalance between suitable donor lungs available and the increasing number of patients considered for LTx reflects in considerable waitlist mortality. Among potential alternatives to address this issue, ex vivo lung perfusion (EVLP) has emerged as a modern preservation technique that allows for more accurate lung assessment and also improvement of lung function. Its application in highrisk donor lungs has been successful and resulted in safe expansion of the donor pool. This article will: (I) review the technical details of EVLP; (II) the rationale behind the method; (III) report the worldwide clinical experience with the EVLP, including the Toronto technique and others; (IV) finally, discuss the growing literature on EVLP application for donation after cardiac death (DCD) lungs.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/2857}
}